Structural and functional characterization of the Staphylococcus aureus virulence factor and vaccine candidate FhuD2
about
Lipoproteins of Gram-Positive Bacteria: Key Players in the Immune Response and VirulenceProtein Crystallography in Vaccine Research and DevelopmentMolecular Basis of Ligand-Dependent Regulation of NadR, the Transcriptional Repressor of Meningococcal Virulence Factor NadAApo, Zn2+-bound and Mn2+-bound structures reveal ligand-binding properties of SitA from the pathogen Staphylococcus pseudintermedius.Vaccine composition formulated with a novel TLR7-dependent adjuvant induces high and broad protection against Staphylococcus aureusIron acquisition in the cystic fibrosis lung and potential for novel therapeutic strategies.One Dose of Staphylococcus aureus 4C-Staph Vaccine Formulated with a Novel TLR7-Dependent Adjuvant Rapidly Protects Mice through Antibodies, Effector CD4+ T Cells, and IL-17A.MF59- and Al(OH)3-Adjuvanted Staphylococcus aureus (4C-Staph) Vaccines Induce Sustained Protective Humoral and Cellular Immune Responses, with a Critical Role for Effector CD4 T Cells at Low Antibody Titers.Recent developments in understanding the iron acquisition strategies of gram positive pathogens.In vivo analysis of Staphylococcus aureus infected mice reveals differential temporal and spatial expression patterns of fhuD2.Surface and Exoproteomes of Gram-Positive Pathogens for Vaccine Discovery.Vaccines for Staphylococcus aureus and Target Populations.Evaluation of Staphylococcus aureus Lipoproteins: Role in Nutritional Acquisition and PathogenicityCrystal structure of FhuD at 1.6 Å resolution: a ferrichrome-binding protein from the animal and human pathogen Staphylococcus pseudintermedius.Demonstration of the functional role of conserved Glu-Arg residues in the Staphylococcus aureus ferrichrome transporter.
P2860
Q26741954-E8EFE2FB-3338-4F46-8033-B9FA4D941653Q28087528-42B53777-74B1-4D7E-966B-F5C712B69385Q28551548-C6FBD36E-2609-4E75-A3BA-8321E2D7ED1CQ34564114-92C6ED0B-BAA4-4814-87D5-FE8B6ABCCF57Q35229369-472E46C3-0197-43D6-900C-7F7CE2DFFAD4Q35862783-0AC7DBD6-17B8-4201-940E-876888AF04ADQ35904895-C2293BE0-072C-41A7-A7CD-D8ADC018E22EQ36032570-FF5CF8C2-5ADA-41BF-951F-8B479107828EQ38415707-686CBDDD-D000-4165-8209-7A9FF935E227Q38636091-F66A7E88-6981-4AE2-B78C-E3A263A4696BQ38958617-EDA048D8-F71C-4BFE-982B-8C4462F5F27FQ38961271-15A3A58B-850A-4348-A668-BA55378D0FB7Q40525128-67937589-FD81-4FD0-AAD8-4B55DDB4F0DCQ40776072-1DD1E8E9-2939-4F04-86B6-24FF41EAF8EAQ54406544-F3D72F2E-B0C9-49D6-A4A9-782350CBE252
P2860
Structural and functional characterization of the Staphylococcus aureus virulence factor and vaccine candidate FhuD2
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Structural and functional char ...... or and vaccine candidate FhuD2
@ast
Structural and functional char ...... or and vaccine candidate FhuD2
@en
Structural and functional char ...... or and vaccine candidate FhuD2
@nl
type
label
Structural and functional char ...... or and vaccine candidate FhuD2
@ast
Structural and functional char ...... or and vaccine candidate FhuD2
@en
Structural and functional char ...... or and vaccine candidate FhuD2
@nl
prefLabel
Structural and functional char ...... or and vaccine candidate FhuD2
@ast
Structural and functional char ...... or and vaccine candidate FhuD2
@en
Structural and functional char ...... or and vaccine candidate FhuD2
@nl
P2093
P2860
P3181
P356
P1433
P1476
Structural and functional char ...... or and vaccine candidate FhuD2
@en
P2093
Enrico Malito
Fabio Bagnoli
Glen Spraggon
Marco Biancucci
Matthew J Bottomley
Mikkel Nissum
Paola Lo Surdo
Ravi P N Mishra
Silvana Savino
Vincenzo Nardi-Dei
P2860
P304
P3181
P356
10.1042/BJ20121426
P407
P577
2013-02-01T00:00:00Z